Westleaf Inc Toronto S.E.

WL

CA9605631048

Pharmaceuticals

End-of-day quote Toronto S.E. Other stock markets
- ^CAD	-

05-29	Decibel Cannabis Company Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	Decibel Cannabis Company Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Westleaf Inc. Raises USD 0.27 Million in Funding

January 13, 2019

Westleaf Inc. has raised 0.27 million in funding. The deal type is private placement.

Latest news about Westleaf Inc

Decibel Cannabis Company Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-29	CI
Decibel Cannabis Company Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Fire & Flower Inc completed the acquisition of brick and mortar retail cannabis operations of Decibel Cannabis Company Inc.(TSXV:DB).	04-09	CI
Decibel Cannabis Company Inc. Appoints Benjamin Sze as Chief Executive Officer	04-08	CI
Decibel Cannabis Company Announces Retirement of Paul Wilson as Chief Executive Officer	03-25	CI
Decibel Cannabis Selling its Retail Cannabis Stores	03-22	MT
Decibel Cannabis Company Inc.(TSXV:DB) dropped from S&P/TSX Venture Composite Index	01-22	CI
Decibel Cannabis Reports Q3 2023 Net Revenue of $30.2 Million	11-16	MT
Decibel Cannabis Company Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
Decibel Cannabis Company Inc.(TSXV:DB) added to S&P/TSX Venture Composite Index	23/10/23	CI
Decibel Cannabis Company Inc. Launches General Admission Blinker Closed Loop Vape System	04/10/23	CI
Decibel Cannabis Company Inc. Announces Resignation of Paul Wilson as Director	29/09/23	CI
Decibel Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C LABS for Distribution in the UK	30/08/23	MT
Decibel Cannabis Company Inc. Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C Labs for Distribution in the United Kingdom	30/08/23	CI
Decibel Cannabis Reports Record Net Revenue of $30.9 Million For Q2 2023	17/08/23	MT
Decibel Cannabis Company Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/08/23	CI
Decibel Cannabis Company Inc. Launches General Admission Edibles	05/07/23	CI
Decibel Cannabis Company Inc. Introduces Vox Brand with Launch of Vox Popz Crushable Pre-Rolls	22/06/23	CI
Decibel Reports Q1 Adjusted Profit of $3.3 Million	29/05/23	MT
Decibel Cannabis Company Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/05/23	CI
Decibel Cannabis Reports Record Q4 Revenue	24/04/23	MT
Decibel Cannabis Company Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	24/04/23	CI
Decibel Cannabis Company Inc. Auditor Raises 'Going Concern' Doubt	23/04/23	CI
Decibel Cannabis Company Inc. Announces Board Changes	12/12/22	CI
Decibel Gains 5% as Reports First International Shipment Of Qwest Flower To Israel	18/11/22	MT

Decibel Cannabis Company Inc. is a Canada-based consumer-focused cannabis company. The Company is focused on premium cannabis flower, vape, cannabis infused, and concentrate products, created through a vertically integrated business model. The Companyâs brands General Admission, Qwest, and Vox are among its portfolio, sold across Canada. The principal products produced and sold by the Company are ultra-premium cannabis flowers, vape cartridges, cannabis infused products, cannabis extracts, cannabis pre-rolls, and, on occasion, bulk amounts of cannabis biomass to other licensed producers in Canada. Its cannabis brands include Qwest, Qwest Reserve, Blendcraft by Qwest, Vox, and General Admission. Qwest cannabis is a small batch grown, nourished with glacial mountain water, hang dried, hand trimmed and cured. The Blendcraft is a small batch grown in British Columbia. Its strains are hand selected based on aroma, flavor and effect, then blended for a smooth smoking experience.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Westleaf Inc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.06 CAD

Average target price

0.3375 CAD

Spread / Average Target

+462.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.66B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.78B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.37B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B

Alternative Medicine

Westleaf Inc Toronto S.E.

Equities

WL

CA9605631048

Pharmaceuticals

Westleaf Inc. Raises USD 0.27 Million in Funding

Latest news about Westleaf Inc

Chart Westleaf Inc

Company Profile

Income Statement Evolution

Ratings for Westleaf Inc

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Alternative Medicine